This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heistad, D. D. Search for Related Content PubMed PubMed Citation Articles by Heistad, D. D.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1.)
© 2000 American Heart Association, Inc.

Editorial

A Progress Report

Donald D. Heistad, Editor-in-Chief, Arteriosclerosis, Thrombosis, Vascular Biology
This is a report summarizing the first few months of our editorship. The commonest complaint that we hear about the Journal is that it takes too long to publish papers. The time from acceptance to publication has been up to 8 to 9 months, which clearly is too long. You may have noticed that issues of ATVB have been larger for several months to allow us to publish the backlog of accepted papers. The time from acceptance to publication has now been reduced to approximately 4 months and soon will be reduced to approximately 3 months. Rapid Communications can be published in an even shorter time. This spring, when all of the papers in the backlog have been published, the Journal will return to its usual size.

We believe that, as the time to publication is reduced, authors will be more inclined to send their "hot" papers to the Journal. We, therefore, urge you to submit those papers to the Journal. We also will continue to speed up the review process. The time to first decision now is about 6 weeks, and we expect to reduce it further.

How can we reduce and maintain the time from acceptance to publication to 3 months or less? We will need to avoid reaccumulation of the backlog. One way to publish more papers, and more rapidly, is to shorten the papers. As indicated in Instructions to Authors in this issue, the number of words in each manuscript now will be limited to 5000. . . . [Full Text of this Article]

This article has been cited by other articles:

				T. Kimura, K. Sato, E. Malchinkhuu, H. Tomura, K. Tamama, A. Kuwabara, M. Murakami, and F. Okajima High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1283 - 1288. [Abstract] [Full Text] [PDF]

				A. Anwar, A.A. Zahid, K.J. Scheidegger, M. Brink, and P. Delafontaine Tumor Necrosis Factor-{alpha} Regulates Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Expression in Vascular Smooth Muscle Circulation, March 12, 2002; 105(10): 1220 - 1225. [Abstract] [Full Text] [PDF]